Family Management Corp Acadia Pharmaceuticals Inc Transaction History

Family Management Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 15, 2018	SELL	$26.84 - $39.14 $791,780 - $1.15 Million	-29,500 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$29.49 - $38.37 $176,940 - $230,219	-6,000 Reduced 16.9%	29,500 $1.11 Million
Q2 2017 Aug 18, 2017	BUY	N/A	35,500	35,500 $990,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

Stay updated on Family Management Corp with notifications on news.